Voyager Therapeutics, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position
Voyager Therapeutics, Inc. (VYGR) had Debt Securities, Available-for-sale, Unrealized Loss Position of $74.50 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $74.50M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $73.50M.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $26.60M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $58.90M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $74.50M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $73.50M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $26.60M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $58.90M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $157.80M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $128.30M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $156.30M 10-K · filed 2026-03-09 |
| 2024-09-30 | $96.00M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $268.20M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $230.70M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $44.20M 10-K · filed 2025-03-11 |
| 2023-09-30 | $81.80M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $11.20M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $19.90M 10-K · filed 2024-02-28 |
| 2022-09-30 | $30.00M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $70.00M 10-Q · filed 2022-08-04 |
| 2021-12-31 | $15.10M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |